Assessment of Patient Perspectives and Barriers to Self-Infusion of Augmentation Therapy for Alpha-1 Antitrypsin Deficiency During the COVID-19 Pandemic.

Colello, Jacob; Ptasinski, Anna; Zhan, Xiang; Kaur, Sundeep; Craig, Timothy

Colello, Jacob; Ptasinski, Anna; Zhan, Xiang; Kaur, Sundeep; Craig, Timothy.

Afiliação

Colello J; Penn State College of Medicine, Hershey, PA, USA.
Ptasinski A; Penn State College of Medicine, Hershey, PA, USA.
Zhan X; Penn State College of Medicine, Hershey, PA, USA.
Kaur S; Penn State College of Medicine, Hershey, PA, USA.
Craig T; Division of Pulmonary, Allergy and Critical Care, Department of Medicine and Pediatrics, Penn State Health, 500 University Drive, Hershey, PA, 17033, USA. tcraig@pennstatehealth.psu.edu.

Pulm Ther ; 8(1): 95-103, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35067906

Palavras-chave

AATD; Alpha-1-antitrpysin; Anti-1-antitrypsin deficiency; Augmentation therapy; COPD; COVID-19; Home therapy; SARS-CoV-2; Survey

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pulm Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google